These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


521 related items for PubMed ID: 12050349

  • 21. Non-Hodgkin's lymphoma (diffuse large B cell lymphoma).
    Copson E.
    Clin Evid; 2005 Jun; (13):1-18. PubMed ID: 16135258
    [No Abstract] [Full Text] [Related]

  • 22. Delayed hepatitis B virus reactivation after cessation of preemptive lamivudine in lymphoma patients treated with rituximab plus CHOP.
    Dai MS, Chao TY, Kao WY, Shyu RY, Liu TM.
    Ann Hematol; 2004 Dec; 83(12):769-74. PubMed ID: 15338194
    [Abstract] [Full Text] [Related]

  • 23. Higher fungal infection rate in elderly patients (more than 80 years old) suffering from diffuse large B cell lymphoma and treated with rituximab plus CHOP.
    Lin PC, Hsiao LT, Poh SB, Wang WS, Yen CC, Chao TC, Liu JH, Chiou TJ, Chen PM.
    Ann Hematol; 2007 Feb; 86(2):95-100. PubMed ID: 17031689
    [Abstract] [Full Text] [Related]

  • 24. Dose-dense R-CHOP-14 supported by pegfilgrastim in patients with diffuse large B-cell lymphoma: a phase II study of feasibility and toxicity.
    Brusamolino E, Rusconi C, Montalbetti L, Gargantini L, Uziel L, Pinotti G, Fava S, Rigacci L, Pagnucco G, Pascutto C, Morra E, Lazzarino M.
    Haematologica; 2006 Apr; 91(4):496-502. PubMed ID: 16537117
    [Abstract] [Full Text] [Related]

  • 25. Interaction between BCL2 and interleukin-10 gene polymorphisms alter outcomes of diffuse large B-cell lymphoma following rituximab plus CHOP chemotherapy.
    Park YH, Sohn SK, Kim JG, Lee MH, Song HS, Kim MK, Jung JS, Lee JJ, Kim HJ, Kim DH.
    Clin Cancer Res; 2009 Mar 15; 15(6):2107-15. PubMed ID: 19276283
    [Abstract] [Full Text] [Related]

  • 26. Aggressive lymphoma involving intracranial epidural region.
    Villela LM, Blanco-Salazar A, Caballero R, Borbolla-Escoboza R.
    J Neurooncol; 2007 Jun 15; 83(2):181-2. PubMed ID: 17332949
    [No Abstract] [Full Text] [Related]

  • 27. Rituximab for the treatment of diffuse large B-cell lymphomas.
    Held G, Pöschel V, Pfreundschuh M.
    Expert Rev Anticancer Ther; 2006 Aug 15; 6(8):1175-86. PubMed ID: 16925484
    [Abstract] [Full Text] [Related]

  • 28. Improved therapeutic outcomes of DLBCL after introduction of rituximab in Korean patients.
    Park YH, Lee JJ, Ryu MH, Kim SY, Kim DH, Do YR, Lee KH, Oh SJ, Kim YK, Suh CW, Heo DS, Ryoo BY, Kim JK, Song HS, Lee WS, Kim HJ, Bang YJ, Yang SH, Sohn SK, Kang YK, Lymphoma Study Division of the Korean Cancer Study Group.
    Ann Hematol; 2006 Apr 15; 85(4):257-62. PubMed ID: 16416337
    [Abstract] [Full Text] [Related]

  • 29. A pilot study of epratuzumab and rituximab in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy in patients with previously untreated, diffuse large B-cell lymphoma.
    Micallef IN, Kahl BS, Maurer MJ, Dogan A, Ansell SM, Colgan JP, Geyer S, Inwards DJ, White WL, Habermann TM.
    Cancer; 2006 Dec 15; 107(12):2826-32. PubMed ID: 17099879
    [Abstract] [Full Text] [Related]

  • 30. Activity and safety of dose-adjusted infusional cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy with rituximab in very elderly patients with poor-prognostic untreated diffuse large B-cell non-Hodgkin lymphoma.
    Fabbri A, Gozzetti A, Rigacci L.
    Cancer; 2011 Aug 01; 117(15):3530; author reply 3531. PubMed ID: 21287541
    [No Abstract] [Full Text] [Related]

  • 31. Rituximab plus CHOP for treatment of diffuse large B-cell lymphoma during second trimester of pregnancy.
    Decker M, Rothermundt C, Holländer G, Tichelli A, Rochlitz C.
    Lancet Oncol; 2006 Aug 01; 7(8):693-4. PubMed ID: 16887487
    [No Abstract] [Full Text] [Related]

  • 32. Combined treatment with rituximab and anthracycline-containing chemotherapy for primary cutaneous large B-cell lymphomas, leg type, in elderly patients.
    Guyot A, Ortonne N, Valeyrie-Allanore L, Bagot M.
    Arch Dermatol; 2010 Jan 01; 146(1):89-91. PubMed ID: 20083704
    [No Abstract] [Full Text] [Related]

  • 33. Large B-cell non-Hodgkin's lymphoma presenting as a laryngeal cyst.
    Agada FO, Mistry D, Grace AR, Coatesworth AP.
    J Laryngol Otol; 2005 Aug 01; 119(8):658-60. PubMed ID: 16102228
    [Abstract] [Full Text] [Related]

  • 34. [Efficacy of CHOP+/-Rituximab-like therapy plus radiation therapy for patients with diffuse large B-cell lymphoma stage I].
    Ueda K, Yokoyama M, Asai H, Koudaira M, Yamada S, Katsube A, Mishima Y, Sakajiri S, Takeuchi K, Saotome T, Terui Y, Takahashi S, Hatake K.
    Gan To Kagaku Ryoho; 2010 May 01; 37(5):853-7. PubMed ID: 20495315
    [Abstract] [Full Text] [Related]

  • 35. Rituximab in combination with CHOP chemotherapy for the treatment of diffuse large B cell lymphoma in Chinese patients.
    Li JM, Wang L, Shen Y, Xia ZG, Chen Y, Chen QS, Chen Y, Zeng XY, You JH, Qian Y, Shen ZX.
    Ann Hematol; 2007 Sep 01; 86(9):639-45. PubMed ID: 17572895
    [Abstract] [Full Text] [Related]

  • 36. Use of rituximab in diffuse large B-cell lymphoma in the salvage setting.
    Gisselbrecht C.
    Br J Haematol; 2008 Dec 01; 143(5):607-21. PubMed ID: 18950460
    [Abstract] [Full Text] [Related]

  • 37. Primary cardiac non-Hodgkin lymphoma presenting with atrial flutter and pericardial effusion.
    Piccaluga PP, Vigna E, Placci A, Agostinelli C, Laterza C, Papayannidis C, Leone O, Martinelli G, Zinzani PL, Baccarani M, Pileri SA.
    Br J Haematol; 2006 Aug 01; 134(4):356. PubMed ID: 16882130
    [No Abstract] [Full Text] [Related]

  • 38. Activity and safety of dose-adjusted infusional cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy with rituximab in very elderly patients with poor-prognostic untreated diffuse large B-cell non-Hodgkin lymphoma.
    Musolino A, Boggiani D, Panebianco M, Vasini G, Salvagni S, Franciosi V, Ardizzoni A.
    Cancer; 2011 Mar 01; 117(5):964-73. PubMed ID: 20960528
    [Abstract] [Full Text] [Related]

  • 39. Inappropriate antidiuretic hormone production in diffuse large B-cell lymphoma.
    Kobayashi K, Yokote T, Akioka T, Takubo T, Tsuji M, Hanafusa T.
    Br J Haematol; 2008 Oct 01; 143(1):2. PubMed ID: 18513282
    [No Abstract] [Full Text] [Related]

  • 40. The therapeutic use of rituximab in non-Hodgkin's lymphoma.
    Marcus R, Hagenbeek A.
    Eur J Haematol Suppl; 2007 Jan 01; (67):5-14. PubMed ID: 17206982
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 27.